Showing results (461-470 of 480) with videos related to

Sort By:
Pageof 48
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Benzimidazolone p38 inhibitorsMark A Dombroski, Michael A Letavic, Kim F McClure, et al.
ACS Medicinal Chemistry Letters|February 21, 2015
Evaluation and synthesis of polar aryl- and heteroaryl spiroazetidine-piperidine acetamides as ghrelin inverse agonistsSuvi T M Orr, Ramsay Beveridge, Samit K Bhattacharya, et al.
Molecular Psychiatry|August 8, 2012
Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brainJ W Steele, S Ju, M L Lachenmayer, et al.
The Journal of Biological Chemistry|August 12, 2003
CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseasesRonald P Gladue, Laurie A Tylaska, William H Brissette, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2012
Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptorDaniel W Kung, Steven B Coffey, Ryan M Jones, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical CandidateSamit K Bhattacharya, Kim Andrews, Ramsay Beveridge, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
Structure-Guided Discovery of Selective Polo-Like Kinase 3 InhibitorsJeremy L Yap, Gabrielle Lovett, Jeremy W Mason, et al.
Molecular Psychiatry|August 2, 2012
Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse modelJ W Steele, M L Lachenmayer, S Ju, et al.
Journal of Medicinal Chemistry|September 10, 2020
Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of FructoseKentaro Futatsugi, Aaron C Smith, Meihua Tu, et al.
Blood|October 16, 2025
Impact of Modernizing Eligibility Criteria on Enrollment and Representation in Acute Myeloid Leukemia Clinical TrialsAndrew Hantel, Yating Wang, Angel Cronin, et al.
Pageof 48